Status:
COMPLETED
Hypoxia Intolerance in Preterm Individuals
Lead Sponsor:
Jozef Stefan Institute
Collaborating Sponsors:
University of Lausanne
Conditions:
Premature Birth
Hypoxia
Eligibility:
MALE
18-30 years
Brief Summary
Reduced Hypoxic Ventilatory Response (HVR) and systemic O2 saturation subsequently leading to blunted aerobic capacity as well as decreased overall physical and cognitive performance are the main phys...
Eligibility Criteria
Inclusion
- prematurely born (gestational age: ≤ 32 weeks; gestational weight ≤ 1500g)
- full-term born
- healthy individuals
- male
Exclusion
- presence of any medical risk factors to exercise and/or exposure to altitude
- presence of any medical condition that would make the protocol unreasonably hazardous for the patient
- smokers
- exposure to altitude above 1000m in the last 2 months
Key Trial Info
Start Date :
April 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04739904
Start Date
April 30 2021
End Date
March 31 2022
Last Update
August 15 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Jozef Stefan Institute
Ljubljana, Slovenia, 1000
2
University of Ljubljana
Ljubljana, Slovenia, 1000
3
Institute of Sport Sciences of the University of Lausanne
Lausanne, Canton of Vaud, Switzerland, 1015